Lucidi Bruno bought AVIR
June 18, 2026 · Form 4 insider transaction
Lucidi Bruno bought 26,700 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,700
Price
$0.00
Total value
N/A
InsiderLucidi Bruno
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after26,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.